Global Neurology Academy
The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
Episodes 17-32 of 94
Richard S. Isaacson, MD
Pierre N. Tariot, MD
Gayatri Devi, MD, MS, FAAN, FACP
Richard S. Isaacson, MD
Pierre N. Tariot, MD
Gayatri Devi, MD, MS, FAAN, FACP
Richard S. Isaacson, MD
Pierre N. Tariot, MD
Gayatri Devi, MD, MS, FAAN, FACP
- MinuteCE®
How Do You Counsel Patients About Amyloid-Related Imaging Abnormalities?
1.25 program creditsRichard S. Isaacson, MD
Pierre N. Tariot, MD
Gayatri Devi, MD, MS, FAAN, FACP
Richard S. Isaacson, MD
Pierre N. Tariot, MD
Gayatri Devi, MD, MS, FAAN, FACP
Richard S. Isaacson, MD
Pierre N. Tariot, MD
Gayatri Devi, MD, MS, FAAN, FACP
- MinuteCE®
What Types of Changes, If Any, Should We Expect with Amyloid-Targeting Therapy?
1.25 program creditsRichard S. Isaacson, MD
Pierre N. Tariot, MD
Gayatri Devi, MD, MS, FAAN, FACP
Richard S. Isaacson, MD
Pierre N. Tariot, MD
Gayatri Devi, MD, MS, FAAN, FACP
Richard S. Isaacson, MD
Pierre N. Tariot, MD
Gayatri Devi, MD, MS, FAAN, FACP
Richard S. Isaacson, MD
Pierre N. Tariot, MD
Gayatri Devi, MD, MS, FAAN, FACP
Richard S. Isaacson, MD
Pierre N. Tariot, MD
Gayatri Devi, MD, MS, FAAN, FACP
Andrew Wilner, MD, FACP, FAAN
Eoin Flanagan, MB, BCh
James Galvin, MD, MPH, FANA
Jon Toledo, MD, PhD
Elaine C. Wirrell, M.D.
Joseph E. Sullivan, MD
- CME/CE
The Future of Muscular Dystrophy Management: Updates for Limb Girdle Muscular Dystrophy
0.25 creditsJennifer Caudle, DO
John F. Brandsema, MD
Vamshi K. Rao, MD
- CME/CE
The Future of Muscular Dystrophy Management: Updates for Duchenne Muscular Dystrophy
0.25 creditsMary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Julie Parsons, MD
Craig Zaidman, MD